Industry supports FDA’s draft guidance on weight management drugs, suggests some refinements
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationCDERGuidancePharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)